Manufacturing NK cells for the clinic: the Spanish experience

Cell & Gene Therapy Insights 2022; 8(8), 1539–1549

DOI: 10.18609/cgti.2022.225

Published: 14 December 2022
Innovator Insight
Antonio Pérez-Martínez, Marty Giedlin, Mariam Ammari

This article will discuss a standardized method for manufacturing a high number of clinical-grade NK cells ideal for infusion into patients, expand on the optimization of protocols, and provide a glimpse into the clinical results of infused NK cells at a hospital in Madrid, Spain.